Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,868.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 2,590.00p
  • 52 Week Low: 1,637.00p
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 57,446
  • Market Cap: £1,233.49m
  • RiskGrade: 128

Restockng drive in China sees Genus's free cash flow more than triple

By Alexander Bueso

Date: Tuesday 08 Sep 2020

LONDON (ShareCast) - (Sharecast News) - Genus posted a big uplift in profits before tax with cash flows more than tripling thanks to strong sales in China.
For the year ending on 30 June, the cattle and swine genetics specialist a 13% jump in sales to reach £551.4m and a 22% rise in profits to £71.0m on adjusted basis, for a 23% improvement in earnings per share to 85.4p.

Free cash flow meanwhile was 352% higher to £35.2m.

The company's boss, Stehpen Wilson, highlighted the strong demand seen in China for its swine products, as large customers looked to restock their herds in the wake of the 2019 African Swine Fever epidemic.

Wilson also called attention to the operational challenges during the period for meat processors in the US due to the Covid-19 pandemic, anticipating that the sector would continue to be impacted during the 2021 financial with management anticipating greater currency headwinds.

The group's porcine genetics business, known as PIC, saw sales rise by 17%, with volumes up by 13% or 6% excluding China, and operating profits growing by 25%.

ABS, which is Genus's dairy and beef cattle arm, meanwhile saw volume growth of 8% with total revenues 9% higher.

Indeed, the firm more than doubled the size of its PIC supply chain in China to capitalise on the country's drive to restock.

Weaker currencies, mainly in Latin America, subtracted £3.4m from topline growth for the year.

comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. Genus's customers' animals produce offspring with greater production efficiency and quality, and our customers use them to supply the global dairy and meat supply chains.

Regarding the outlook, despite the likelihood that Covid-19 would continue to heavily impact "many sectors" across the globe for some time, Genus expected trading over the year ahead to be in line with management's expectations.

At period end, the group's net debt, including £24.7m resulting from the adoption of IFRS 16, stood at £102.6m and at 0.9 times the company's earnings before interest, taxes, depreciation and amortisation.

Genus bumped up its dividend payout by 5% to 29.1p.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,868.00p
Change Today -30.00p
% Change -1.58 %
52 Week High 2,590.00p
52 Week Low 1,637.00p
Volume 57,446
Shares Issued 66.03m
Market Cap £1,233.49m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 13-May-2024

Time Volume / Share Price
16:11 2 @ 1,866.00p
16:35 34,896 @ 1,868.00p
16:35 2 @ 1,868.00p
16:35 181 @ 1,868.00p
16:35 90 @ 1,868.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page